Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupivacaine + betamethasone is a combination medication that pairs an amide local anesthetic (bupivacaine) with a corticosteroid (betamethasone). This combination is commonly used in clinical practice for epidural injections and other local/regional anesthetic procedures. ## Pharmacology and Mechanism of Action Bupivacaine works by stabilizing the neuronal membrane through inhibition of ionic fluxes required for the initiation and conduction of nerve impulses, thereby producing local anesthetic effects[5]. It blocks voltage-gated sodium channels at the intracellular portion of their pore-forming transmembrane segments, preventing sodium ions from passing through the channel's pore[5]. This stabilizes the membrane at rest and prevents neurotransmission. Betamethasone, as a corticosteroid, provides anti-inflammatory effects. When used in combination with bupivacaine, it can help reduce thermal hyperalgesia in models of radiculopathy[1]. ## Clinical Applications This combination is used for: - Epidural injections for treatment of low back pain and sciatica[1] - Local or regional anesthesia for surgery, dental procedures, and diagnostic procedures[3][4] - Management of pain in radiculopathy[1] ## Efficacy and Research Findings Research has shown that in animal models of radiculopathy, betamethasone (either alone or in combination with bupivacaine) significantly reduced thermal hyperalgesia compared to saline or bupivacaine alone[1]. This provides clinical support for the use of epidural steroids in pain management. ## Administration The combination is typically administered via: - Epidural injection - Infiltration techniques - Peripheral nerve block techniques - Central neural techniques such as lumbar and caudal epidural blocks The specific concentrations and presentations of bupivacaine are recommended for each type of block indicated to produce local or regional anesthesia or analgesia[4]. This combination represents an important tool in pain management, particularly for inflammatory conditions, though its use requires careful consideration of potential risks and physicochemical stability issues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + betamethasone.